NCT03332186View on ClinicalTrials.gov

A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

October 22, 2018

Study Completion Date

October 22, 2018

Conditions
Myocardial FailureCardiac FailureCongestive Heart FailureKidney FailureRenal Failure
Interventions
DRUG

BMS-986231

Intravenous infusion administration

Trial Locations (3)

170 00

Local Institution, Prague

05-825

Samodzielny Publiczny Secjalistyczny Szpital Zachodni im. sw. Jana Pawla II, Grodzisk Mazowiecki

31-559

Specjalistyczne Centrum Medyczne Panacea Poznan, Krakow

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY